GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 133 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,096,000 | +505.0% | 341,878 | +322.7% | 0.24% | +507.7% |
| Q2 2022 | $677,000 | -11.3% | 80,878 | -8.0% | 0.04% | +56.0% |
| Q1 2022 | $763,000 | -22.9% | 87,929 | +0.6% | 0.02% | -30.6% |
| Q4 2021 | $989,000 | -12.6% | 87,429 | -2.9% | 0.04% | +5.9% |
| Q3 2021 | $1,132,000 | +41.3% | 90,077 | -8.7% | 0.03% | +36.0% |
| Q2 2021 | $801,000 | -13.6% | 98,633 | -1.6% | 0.02% | -3.8% |
| Q1 2021 | $927,000 | – | 100,254 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |